We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck’s Rating Falls Due to Patent Losses, Vioxx Litigation
Merck’s Rating Falls Due to Patent Losses, Vioxx Litigation
February 19, 2007
Fitch Ratings downgraded Merck’s ratings as the company faces major patent losses and continued liability damages from Vioxx lawsuits.